Navigation Links
Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
Date:5/29/2008

New Data to be Presented at ASCO Shows Survival Benefit in Complete and

Partial Responders Compared with Chemotherapy Alone

BERKELEY HEIGHTS, N.J., May 29 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced the results of long-term followup from a Phase 3 trial of the Company's lead oncology product, Genasense(R) (oblimersen sodium) Injection, in patients with chronic lymphocytic leukemia (CLL). With 5 years of followup, new data show that patients who achieved either a complete response (CR -- the trial's primary endpoint) or a partial response (PR) have also achieved a statistically significant increase in overall survival. The data will be featured in an oral presentation at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago on June 2, 2008.

In the Phase 3 trial, 241 patients with relapsed or refractory CLL were randomly assigned to receive chemotherapy with fludarabine plus cyclophosphamide (Flu/Cy) with or without Genasense. This study achieved its primary endpoint, which was a statistically significant increase in the proportion of patients who achieved a complete or nodular partial response (CR) with the addition of Genasense to the Flu/Cy regimen. (17% vs. 7%; P=0.025). In addition, the median duration of CR was also significantly longer for patients treated with Genasense (median not reached but estimated to exceed 36 months vs. 22 months).

Previous analyses showed a significant benefit in overall survival accrued to patients who attained CR. Extended followup has shown that all major responses (CR+PR) achieved with Genasense have now been associated with significantly increased overall survival compared with all major responses achieved with chemotherapy alone (median = 56 months vs. 38 months, respectively). At 5 years, 22 of 49 (45%) responders in the Genasense group remain alive compared with 13 of 54 (24%) responders in the chemotherapy-only group (HR =
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
2. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
3. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
6. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Today, UL LLC, a global safety ... of electronic quality management systems (EQMS) and quality ... leverage the strengths of both organizations to support ... and comprehensive advice and guidance for successful global ... to UL,s strength in regulatory services and testing ...
(Date:5/29/2015)... , May 29, 2015  Anpac Bio-Medical Science Co., ... Yu and the Anpac research team are introducing ... Science (NPLS) organizers published as, "game changing" and "breakthrough" ... Society of Clinical Oncology (ASCO) Annual Meeting in ... 2, 2015. An accomplished inventor with ...
(Date:5/29/2015)...  Fair Rate Funding, a leader in TV mesh ... Delaware found Thursday that Boston Scientific,s ... organ prolapse (POP) and Stress Urinary Incontinence (SUI) in ... the design flaws from the plaintiff, Deborah Barba ... Transvaginal mesh, also known as TV mesh ...
Breaking Medicine Technology:UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3
(Date:5/29/2015)... 2015 “In the current environment ... federal regulations, we provide education that will help ... are suffering from pain, within the boundaries of ... professor of rehabilitation medicine and President/Medical Director of ... Kansas. , A new flight of PAINWeekEnd Regional ...
(Date:5/29/2015)... Denver, CO (PRWEB) May 29, 2015 ... video from The Denver Foundation, community comes together to ... lead, to build neighborhoods and awareness of critical issues. ... in Metro Denver and beyond. , "What Community Does" ... oldest community foundation in Colorado, and released during the ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... May 29, 2015 The Recovery ... substance abuse, and co-occurring mental health treatment facility, ... cutting for the general public on June 1st, ... The Recovery Village at Palmer Lake will offer ... programming, utilizing traditional and evidence-based therapies, in a ...
(Date:5/29/2015)... 2015 According to a recent HealthDay article, ... workers has a substance abuse problem - the data, which ... adults with full-time jobs, revealed that 9.5% of those workers ... (1) The National Council on Alcoholism and Drug Dependence (NCAAD) ... an estimated 70% of the 14.8 million illicit drug users ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4
... May 17, 2011 - It is important for health care ... public health authorities. But there is evidence of a reluctance ... concerns for both patient privacy and provider confidentiality. Dr. Khaled ... have developed a secure protocol and system that would solve ...
... 17 May 2011 There is a significant need for ... One strategy has been to determine whether physiologic ... also be useful in estimating the risk for developing this ... Swiss researchers in the current issue of Biological Psychiatry ...
... 17 May, 2011 - New analysis published by the UK ... of abortion in Poland has led to the development of ... quality of care or accountability. Since abortion became illegal in ... hospitals has fallen by 99%. The private trade in abortions ...
... A new book edited by researchers at Worcester Polytechnic ... Medicine provides a comprehensive look at the science and ... of death---heart disease. "Regenerating the Heart: Stem Cells and ... Gaudette, associate professor of biomedical engineering at WPI, and ...
... This release is available in French and ... belonging to the herpesviruses family, which also includes the herpes ... factors that might cause multiple sclerosis, a condition affecting the ... confirmed by University of Granada scientists that analyzed ...
... entrepreneur Ray Thurston decided to make a $3-million gift to ... Neurological Institute, writing a check was only part of the ... the business expertise that Thurston brought to the table. ... company he sold to UPS in 1995sat down with Nader ...
Cached Medicine News:Health News:CHEO Research Institute develops secure protocol for data disclosure 2Health News:A 'brain wave' test for schizophrenia risk? 2Health News:Abortions generate $95 million a year for Polish doctors as women use illegal private sector 2Health News:New book explores stem cell therapies for heart disease 2Health News:A virus similar to herpes could be a risk factor for multiple sclerosis 2Health News:Philanthropist connects strategic plan to research 2
... Collection Tubes are 100% plastic capillary blood ... of applications, the Capillary Collection Tubes are ... and a micro tube.,The capillary tube uses ... the micro tube thereby eliminating the tendency ...
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... is an enzyme immunoassay test in a microwell ... 90-minute incubation. The results are objective and ... The Bio-Rad Mumps IgG test is intended ... IgG antibodies to mumps virus in human serum ...
... for Toxoplasmosis has progressed from ... dye test to immunoflourescence, latex ... In addition to Toxo ... both Toxo IgM immunocapture and ...
Medicine Products: